ORAL IMMEDIATE RELEASE FORMULATION OF A POORLY WATERSOLUBLE ACTIVE SUBSTANCE
The invention is related to an oral immediate release formulation of Benzazepin -1- acetic acid derivatives comprising: a) said active substance in an amount of up to 65% of the total weight of the formulation; b) at least 10% w/w an alkaline compound or a mixture of alkaline compounds; c) between 0...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention is related to an oral immediate release formulation of Benzazepin -1- acetic acid derivatives comprising: a) said active substance in an amount of up to 65% of the total weight of the formulation; b) at least 10% w/w an alkaline compound or a mixture of alkaline compounds; c) between 0.1 and 10% of one or more surfactants, and d) optionally comprises auxiliary materials an amount of between 1% and 45% of the total weight of the formulation.
La invencion se refiere a una formulacion oral de liberacion inmediata de derivados del acido benzazepin-1-acetico que comprende a) dicha sustancia activa en una cantidad de hasta 65% del peso total de la formulacion; b) al menos 10% p/p de un compuesto alcalino o una mezcla de compuestos alcalinos; c) entre 0.1 y 10% p/p de uno o mas agentes tensioactivos, y d) opcionalmente materiales auxiliares en una cantidad comprendida entre 1% y 45% del peso total de la formulacion. |
---|